Bruker MALDI Biotyper sirius and sirius one systems awarded ACT label for environmental accountability
Recognition underscores Bruker’s commitment to sustainability and innovation in microbial detection
Recognition underscores Bruker’s commitment to sustainability and innovation in microbial detection
FDA registration represents an important milestone in expanding access to the technology for healthcare professionals in the United States
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
Next-generation magnetic bead-based kit designed for fast and efficient nucleic acid purification from diverse sample types
The SureSelect XT HS2 DNA Reagent Kit is Agilent’s most cutting-edge library prep and target enrichment solution for Illumina sequencing
Join us on Thursday, December 10, to discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
New social media channels will better serve the clinical community by making it even easier to stay up to date
Collaboration follows successful acquisition and commercialization of Oxsed, an Oxford University Spin-out, to scale OxLAMP rapid COVID-19 test globally
Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development
How is globalization impacting the transmission of infectious diseases and what response is required from global health networks for greater security?
Join us on Thursday, December 17, to learn ways to improve time to result in critical pathways such as sepsis
High Quality Assays with Reproducible and Reliable Results
250 µl, pre-stained, Strep-tagged recombinant proteins (10–250 kD), including three pink reference bands (25, 50, 75 kD), 50 applications
Discover how cutting-edge AI-driven automation systems are transforming cell culture workflows and lab productivity
Essential techniques for PCR, mass spec sample prep, direct titration, assay development, and more
Best practices and smarter sourcing for clinical measurement success
Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free
Latest release accelerates hit-to-candidate progression by keeping teams aligned, eliminating inefficiencies and enabling better prioritization decisions
FDA clearance of MBT FAST™ Shuttle US IVD and MBT Compass HT CA software improves workflow efficiency and accelerates data processing and FDA approval of expanded reference library increases coverage to 549 validated microbial species
"accelerate innovation, improve accuracy, and drive smarter decision-making"